Eli Lilly

IRS: 350470950
LLY
Eli Lilly

Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology.

Founded
1876 (145 years)
CEO
David A. Ricks
Investor RelationsSEC
Revenue
23 billion (2020)

Want to see more? Sign up!